Gary E. Friedlaender

Gary E. Friedlaender is a declared insider of Biomimetic Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 28 March 2008 and 1 March 2013, the trades on record add up to 44 filings.

The open-market record is one-sided, with 17 purchases worth €144k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 6 option exercises.

Half of the purchases are above €1,240 and half below.

On 5 March 2013 came the latest disclosure, a transaction in Biomimetic Therapeutics, Inc. The clock since the last published purchase (4 April 2012) now reads 5,315 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.